Aditxt, a Nasdaq-listed biotechnology company, has unveiled its Bitcoin strategic program, bitXbio. This initiative aims to integrate Bitcoin funding strategies with equity to enhance the company's capitalization and monetization efforts in public markets. Aditxt plans to establish a Bitcoin reserve, contingent on available funds, to bolster its market value and support its commercialization activities, while exploring new opportunities within the digital asset economy.